West Paces Advisors Inc. Atri Cure, Inc. Transaction History
West Paces Advisors Inc.
- $410 Billion
- Q4 2024
A detailed history of West Paces Advisors Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 25 shares of ATRC stock, worth $863. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$863
Previous $701,000
8.99%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
229Shares Held
47.1MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$161 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$159 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$132 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$101 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$87.3 Million0.51% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.6B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...